Cargando…
Antiepileptic Drugs.
The thoroughly revised, updated Fifth Edition of this classic is the most comprehensive, current, and authoritative reference on all anticonvulsants available today. This edition features detailed profiles of newer drugs--including levetiracetam, oxcarbazepine, tiagabine, topiramate, and zonisamide-...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Philadelphia :
Wolters Kluwer Health,
2002.
|
| Edición: | 5th ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Antiepileptic drugs; contents; contributing authors; preface; section i general principles; 1 principles of antiepileptic drug action; 2 neurophysiologic effects of antiepileptic drugs; 3 discovery and preclinical development of antiepileptic drugs; 4 new antiepileptic drug development: medical perspective; 5 clinical development of antiepileptic drugs: industry perspective; 6 the development of antiepileptic drugs: regulatory perspective; 7 antiepileptic drug monotherapy in adults: selection and use in new-onset epilepsy; 8 combination therapy and drug interactions.
- 9 laboratory monitoring of antiepileptic drugs 10 safety monitoring of antiepileptic drugs; 11 use of antiepileptic drugs in children; 12 antiepileptic drug use in women; 13 epilepsy in the elderly; 14 treatment of status epilepticus; 15 prevention of epileptogenesis; section ii benzodiazepines; 16 mechanisms of action; 17 chemistry, biotransformation, and pharmacokinetics; 18 clinical efficacy and use in epilepsy; 19 adverse effects; section iii carbamazepine; 20 mechanisms of action; 21 chemistry, biotransformation, and pharmacokinetics; 22 interactions with other drugs.
- 23 clinical efficacy and use in epilepsy24 clinical efficacy and use in other neurologic disorders; 25 clinical efficacy and use in psychiatric disorders; 26 adverse effects; section iv felbamate; 27 felbamate; section v gabapentin; 28 mechanisms of action; 29 chemistry, biotransformation, pharmacokinetics, and interactions; 30 clinical use; 31 clinical efficacy and use in other neurological disorders; 32 clinical efficacy and use in psychiatric disorders; 33 adverse effects; section vi lamotrigine; 34 mechanisms of action; 35 chemistry, biotransformation, and pharmacokinetics.
- 36 interaction with other drugs37 clinical efficacy and use in epilepsy; 38 efficacy and use in psychiatric disorders; 39 adverse effects; section vii i levetiracetam; 40 mechanisms of action; 41 chemistry, biotransformation, pharmacokinetics, and drug interactions; 42 clinical use; 43 adverse experiences; section viii oxcarbazepine; 44 mechanisms of action; 45 chemistry, biotransformation, and pharmacokinetics; 46 interactions with other drugs; 47 clinical efficacy and use in epilepsy; 48 clinical efficacy and use in psychiatric disorders; 49 adverse effects.
- Section ix phenobarbital and other barbiturates50 mechanisms of action; 51 chemistry, biotransformation, and pharmacokinetics; 52 interactions with other drugs; 53 clinical efficacy and use in epilepsy; 54 clinical efficacy and use in nonepileptic disorders; 55 adverse effects; 56 methylphenobarbital; section x phenytoin and other hydantoins; 57 mechanisms of action; 58 chemistry and biotransformation; 59 interactions with other drugs; 60 clinical efficacy and use in epilepsy; 61 clinical efficacy and use in other neurological disorders; 62 clinical efficacy and use in psychiatric disorders.